NO981269L - Forbindelser som forsterker virkningen av retinoider - Google Patents
Forbindelser som forsterker virkningen av retinoiderInfo
- Publication number
- NO981269L NO981269L NO981269A NO981269A NO981269L NO 981269 L NO981269 L NO 981269L NO 981269 A NO981269 A NO 981269A NO 981269 A NO981269 A NO 981269A NO 981269 L NO981269 L NO 981269L
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen atom
- alkyl group
- represents hydrogen
- group
- retinoids
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000000694 effects Effects 0.000 title abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
- -1 pyridinediyl group Chemical group 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D267/20—[b, f]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D281/16—[b, f]-condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thin Film Transistor (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24263995 | 1995-09-21 | ||
| JP15058296 | 1996-06-12 | ||
| PCT/JP1996/002709 WO1997011061A1 (en) | 1995-09-21 | 1996-09-20 | Compounds potentiating retinoid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO981269D0 NO981269D0 (no) | 1998-03-20 |
| NO981269L true NO981269L (no) | 1998-05-20 |
Family
ID=26480129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO981269A NO981269L (no) | 1995-09-21 | 1998-03-20 | Forbindelser som forsterker virkningen av retinoider |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US5929069A (enExample) |
| EP (1) | EP0906907B1 (enExample) |
| KR (1) | KR100484294B1 (enExample) |
| CN (1) | CN1121395C (enExample) |
| AT (1) | ATE214055T1 (enExample) |
| AU (1) | AU7001596A (enExample) |
| CA (1) | CA2233012A1 (enExample) |
| DE (1) | DE69619711T2 (enExample) |
| DK (1) | DK0906907T3 (enExample) |
| EA (1) | EA002123B1 (enExample) |
| NO (1) | NO981269L (enExample) |
| TW (1) | TW420667B (enExample) |
| WO (1) | WO1997011061A1 (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5929069A (en) * | 1995-09-21 | 1999-07-27 | Institute Of Medicinal Molecular Design, Inc. | Compounds activating pharmacological effects of retinoids |
| WO1999024415A1 (en) * | 1997-11-12 | 1999-05-20 | Institute Of Medicinal Molecular Design, Inc. | Retinoid receptor agonists |
| JP4204657B2 (ja) * | 1997-12-05 | 2009-01-07 | 有限会社ケムフィズ | 糖尿病の予防・治療剤 |
| US6083973A (en) * | 1998-03-09 | 2000-07-04 | Syntex (U.S.A.) Inc. | Methods for inhibiting mucin secretion using RAR α selective antagonists |
| JP4693247B2 (ja) | 1999-04-28 | 2011-06-01 | 有限会社ケムフィズ | 複素環カルボン酸誘導体 |
| US7144880B2 (en) | 1999-04-30 | 2006-12-05 | Regents Of The University Of Michigan | Compositions relating to novel compounds and targets thereof |
| US20060025388A1 (en) | 1999-04-30 | 2006-02-02 | Glick Gary D | Compositions and methods relating to novel compounds and targets thereof |
| ATE258439T1 (de) * | 1999-04-30 | 2004-02-15 | Univ Michigan | Verwendung von benzodiazepinen zur behandlung von apoptose-induzierten autoimmunerkrankungen |
| JP4654126B2 (ja) * | 2003-03-20 | 2011-03-16 | 財団法人乙卯研究所 | 器官形成方法 |
| GB0308335D0 (en) | 2003-04-10 | 2003-05-14 | Novartis Ag | Organic compounds |
| WO2005087219A1 (ja) | 2004-03-10 | 2005-09-22 | Research Foundation Itsuu Laboratory | 記憶固定促進剤 |
| WO2005099759A1 (ja) * | 2004-04-16 | 2005-10-27 | Institute Of Medicinal Molecular Design. Inc. | 動脈硬化症の予防及び／又は治療のための医薬 |
| WO2007053193A2 (en) | 2005-06-01 | 2007-05-10 | The Regents Of The University Of Michigan | Unsolvated benzodiazepine compositions and methods |
| WO2007029760A1 (ja) * | 2005-09-09 | 2007-03-15 | R & R Inc. | 腸疾患の予防及び／又は治療のための医薬 |
| WO2007053725A2 (en) | 2005-11-01 | 2007-05-10 | The Regents Of The University Of Michigan | Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties |
| MX2008015488A (es) | 2006-06-09 | 2009-02-12 | Univ Michigan | Composiciones y metodos relacionados con compuestos novedosos y objetivos de los mismos. |
| JP2008081427A (ja) * | 2006-09-27 | 2008-04-10 | R&R Inc | 分泌障害性疾患の予防及び／又は治療のための医薬 |
| US7902260B2 (en) * | 2007-02-28 | 2011-03-08 | Kemphys Ltd. | Medicament for preventive and/or therapeutic treatment of lower urinary tract symptom |
| MX2009009645A (es) | 2007-03-09 | 2009-11-19 | Univ Michigan | Composiciones y metodos relacionados con nuevos compuestos y objetivos de los mismos. |
| WO2009022722A1 (ja) | 2007-08-15 | 2009-02-19 | Research Foundation Itsuu Laboratory | ３環系アミン化合物 |
| AU2008298870C1 (en) | 2007-09-14 | 2014-10-09 | The Regents Of The University Of Michigan | F1F0-ATPase inhibitors and related methods |
| CN101918375A (zh) | 2007-11-06 | 2010-12-15 | 密歇根大学董事会 | 在皮肤病症的治疗中有用的苯并二氮杂*酮化合物 |
| US8497307B2 (en) | 2008-09-11 | 2013-07-30 | The Regents Of The University Of Michigan | Aryl guanidine F1F0-ATPase inhibitors and related methods |
| WO2010121164A2 (en) | 2009-04-17 | 2010-10-21 | The Regents Of The University Of Michigan | 1,4-benzodiazepinone compounds and their use in treating cancer |
| EP2470020A4 (en) | 2009-09-18 | 2013-03-13 | Univ Michigan | BENZODIAZEPINONE COMPOUNDS AND TREATMENT METHODS THEREWITH |
| JP5442021B2 (ja) | 2009-09-28 | 2014-03-12 | 日本曹達株式会社 | 含窒素ヘテロ環化合物およびその塩ならびに農園芸用殺菌剤 |
| WO2011062765A2 (en) | 2009-11-17 | 2011-05-26 | The Regents Of The University Of Michigan | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| EP2501695B1 (en) | 2009-11-17 | 2018-08-29 | The Regents Of The University Of Michigan | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| US9249161B2 (en) | 2010-12-02 | 2016-02-02 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| WO2012112623A2 (en) * | 2011-02-14 | 2012-08-23 | Sloan-Kettering Institute For Cancer Research | Rxrg modulators for the treatment of cancer |
| US9422292B2 (en) | 2011-05-04 | 2016-08-23 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| US9328117B2 (en) | 2011-06-17 | 2016-05-03 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| US9624244B2 (en) | 2012-06-06 | 2017-04-18 | Constellation Pharmaceuticals, Inc. | Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof |
| TWI602820B (zh) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | 溴域抑制劑及其用途 |
| CN103304494B (zh) * | 2013-06-20 | 2015-05-27 | 河北大学 | 茚(1,2-b)喹喔啉-11-酮肟衍生物及其制备方法和用途 |
| US9969747B2 (en) | 2014-06-20 | 2018-05-15 | Constellation Pharmaceuticals, Inc. | Crystalline forms of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide |
| KR200489267Y1 (ko) | 2018-09-20 | 2019-05-23 | 김은진 | 폭 조절형 옷걸이 |
| KR200490993Y1 (ko) | 2019-06-14 | 2020-02-04 | 이현봉 | 구김방지기능을 구비한 바지걸이 |
| CN114702454A (zh) * | 2022-03-29 | 2022-07-05 | 江西师范大学 | 5-烷基-11-芳基-5H-二苯并[b,e][1,4]二氮杂卓衍生物的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04211071A (ja) * | 1990-03-05 | 1992-08-03 | Hokuriku Seiyaku Co Ltd | 多環式化合物 |
| US5929069A (en) * | 1995-09-21 | 1999-07-27 | Institute Of Medicinal Molecular Design, Inc. | Compounds activating pharmacological effects of retinoids |
| JP4204657B2 (ja) * | 1997-12-05 | 2009-01-07 | 有限会社ケムフィズ | 糖尿病の予防・治療剤 |
-
1996
- 1996-09-20 US US08/710,657 patent/US5929069A/en not_active Expired - Lifetime
- 1996-09-20 TW TW085111550A patent/TW420667B/zh not_active IP Right Cessation
- 1996-09-20 KR KR10-1998-0702114A patent/KR100484294B1/ko not_active Expired - Fee Related
- 1996-09-20 WO PCT/JP1996/002709 patent/WO1997011061A1/ja not_active Ceased
- 1996-09-20 DK DK96931263T patent/DK0906907T3/da active
- 1996-09-20 CN CN96198386A patent/CN1121395C/zh not_active Expired - Fee Related
- 1996-09-20 EP EP96931263A patent/EP0906907B1/en not_active Expired - Lifetime
- 1996-09-20 EA EA199800318A patent/EA002123B1/ru not_active IP Right Cessation
- 1996-09-20 DE DE69619711T patent/DE69619711T2/de not_active Expired - Lifetime
- 1996-09-20 CA CA002233012A patent/CA2233012A1/en not_active Abandoned
- 1996-09-20 AT AT96931263T patent/ATE214055T1/de not_active IP Right Cessation
- 1996-09-20 AU AU70015/96A patent/AU7001596A/en not_active Abandoned
-
1998
- 1998-03-20 NO NO981269A patent/NO981269L/no unknown
-
1999
- 1999-04-09 US US09/288,618 patent/US6121256A/en not_active Expired - Fee Related
-
2001
- 2001-04-20 US US09/838,272 patent/US6476017B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR100484294B1 (ko) | 2005-09-09 |
| TW420667B (en) | 2001-02-01 |
| CN1121395C (zh) | 2003-09-17 |
| EA199800318A1 (ru) | 1998-10-29 |
| WO1997011061A1 (en) | 1997-03-27 |
| DE69619711T2 (de) | 2002-10-17 |
| EP0906907A4 (enExample) | 1999-04-07 |
| EP0906907B1 (en) | 2002-03-06 |
| US20010039272A1 (en) | 2001-11-08 |
| KR19990063661A (ko) | 1999-07-26 |
| DE69619711D1 (de) | 2002-04-11 |
| EA002123B1 (ru) | 2001-12-24 |
| US6121256A (en) | 2000-09-19 |
| US5929069A (en) | 1999-07-27 |
| NO981269D0 (no) | 1998-03-20 |
| DK0906907T3 (da) | 2002-04-22 |
| AU7001596A (en) | 1997-04-09 |
| ATE214055T1 (de) | 2002-03-15 |
| US6476017B2 (en) | 2002-11-05 |
| EP0906907A1 (en) | 1999-04-07 |
| CA2233012A1 (en) | 1997-03-27 |
| CN1202160A (zh) | 1998-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO981269D0 (no) | Forbindelser som forsterker virkningen av retinoider | |
| NO20002169L (no) | Nye pyridazinderivater og medikamenter inneholdende disse som effektive ingredienser | |
| EP0976748A4 (en) | PYRROLIDIN DERIVATIVES HAVING A PHOSPHOLIPASE A2 INHIBITING EFFECT | |
| DE69331414D1 (de) | Depsipeptide, herstellung und anwendung | |
| DE69426602D1 (de) | 2,3-diaminopropionsäurederivate | |
| DK0807630T3 (da) | Heterocykliske forbindelser | |
| DE69330639D1 (de) | Methotrexat-derivate | |
| ATE151073T1 (de) | Pyridincarboximidamide und deren anwendung | |
| DK0676399T3 (da) | Methotrexaderivater | |
| AU6117698A (en) | Antiviral agents | |
| DE69017774D1 (de) | Benzothiazol-derivate als fungizide. | |
| AU740079C (en) | Antirheumatic agents | |
| DE59004173D1 (de) | Verwendung von 2,2,6,6-Tetramethyl-4-aminopiperidinamiden als Fungizide. | |
| NO963369L (no) | Nye indan-2-mercaptoacetylamid-disulfidderivater som er anvendbare som inhibitorer av enkefalinase | |
| DE69311999D1 (de) | Verfahren zur Herstellung von Amino-Thiadiazolylacetylhaliden |